Legend Biotech
killed car expressing tumor cells in preclinical studies | Legend Biotech
Company
Deck Type
IPO
Sector
Industry
Deck date
May 2020
Slide
26 of 42
Related slides by other companies
SentiBio
SPAC
October 2021
senti discovered as a safety antigen that is highly expressed in healthy epithelial cells but not in tumor cells | SentiBio
Enochian Biosciences
Investor Presentation
January 2024
cell and gene platforms engineered dendritic cell therapeutic vaccine solid tumors engineered cell therapeutic vaccine | Enochian Biosciences
Mink Therapeutics
IPO
October 2021
cells show tumor killing potential | Mink Therapeutics
Immatics
Investor Presentation
November 2023
targeting mechanism of action | Immatics
Other recent decks by Legend Biotech
See all presentations (6 decks)
Investor Presentation
April 2025
Results
November 2024
Investor Presentation
January 2024
Results
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights